UNSPSC 51102854: Hydrocortisone/iodoquinol

This classification denotes a combination drug defined by the U.S. Department of Veterans Affairs in its (VA's) National Drug File (NDF), which falls under VA Drug Class DE250. This VA Drug Class (DE250) classifies this compound as belonging to the group ANTI-INFECTIVE/ANTI-INFLAMMATORY COMBINATIONS, TOPICAL.

UNSPSC 51102854 Hydrocortisone/iodoquinol is a Commodity code with nominal pharmaceutical scope, but recent state and local procurement activity shows a substantive mismatch: the four recent opportunities posted under this code involve naloxone and drug deactivation systems, direct-to-manufacturer prescription programs, general medical and first aid supplies for emergency response, and generic multi-source pharmaceuticals through cooperative purchasing — none of which center on topical dermatological compounds. State and local governments do procure pharmaceutical products and medical supplies through various issuing bodies, but the tagged opportunities reflect broader pharmacy and emergency medical supply sourcing rather than the specific active pharmaceutical ingredient this code nominates. The issuing bodies include county health departments (Seminole County, Florida), state health and human services commissions (Texas HHS), municipal fire and rescue divisions (City of Tampa), and multistate cooperative purchasing alliances (MMCAP, administered by the Minnesota Department of Administration). Sourcing patterns show reliance on both direct competitive bidding and cooperative purchasing vehicles.

Recent activity geographically spans Florida, Texas, Minnesota, and Oregon, with the most visible activity in cooperative purchasing frameworks serving multiple jurisdictions simultaneously. Representative recent opportunities include Seminole County's IFB 60459723LAS (posted June 30, 2026, due July 26, 2023) for 1,900 units of naloxone and 800 safe drug deactivation systems annually to support community health initiatives; the City of Tampa's IFB 26P00145 (posted March 25, 2026, due March 13, 2026) for 169 line items of medical and first aid supplies estimated at $700,000.00 for the Tampa Fire Department Rescue Division, designated as a sheltered market opportunity with a 5 percent bid discount for certified Small Local Business Enterprises; the Texas HHS RFI HHS0017013 (posted April 3, 2026) exploring direct-to-manufacturer prescription programs; and MMCAP's RFP S1070000015802 (posted January 20, 2026, due March 26, 2026) for generic multi-source pharmaceuticals and OTC products distributed through authorized wholesalers to participating state and local facilities. The code shows little relevant recent activity aligned with its nominal scope.